AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...

The investment strengthens Maryland’s position as a biotech hub and reflects AstraZeneca’s commitment to local job creation ...

Larry Hogan speaks to members of the media at the AstraZeneca facility in Gaithersburg, Md., on Aug. 26, 2024. Larry Hogan ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

AstraZeneca opens a $300M CAR-T cell therapy facility in Rockville, boosting Maryland's life sciences sector and creating ...

Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to ...

The facility to manufacture cell therapies for cancer research is part of the company's push to invest $3.5B in its U.S.

Local leaders and state officials are trying to help federal workers find stability and chart a new path forward in Maryland.

The reduction will occur as part of a consolidation of research and development into three global centers: at MedImmune, its ...

AstraZeneca posts Q1 revenue of $13.59 billion and a strong EPADS beat; oncology leads growth as China's tax probe and halts ...

The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients. The U.K-based ...